Product and Services Finder
|
|
|
|
|
|
|
|
|
CoreRx Pharmaceuticals CoreRX™ streamlines the drug development process for biotechnology and pharmaceutical innovators with pre-formulation, formulation development, analytical development and clinical manufacturing.
Clinical Manufacturing
CoreRx™ offers diversified technical resources, capacity, flexibility, and the experience to develop and manufacture virtually any clinical dosage form with...
Formulation Development
CoreRx™ scientists have extensive expertise in drug formulation development. We have skill providing innovative solutions to any issues that may arrive in...
|
Crucell Biologics, Inc. Crucell is a global biopharmaceutical company dedicated to bringing meaningful innovation to global health. We do this by discovering, developing, manufacturing and marketing products that combat major threats to the...
|
Cyntellect Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing technology. Cyntellect's products support key applications to advance life science research, biopharmaceutical production,...
LEAP
The LEAP™ is a microplate-based cytometry system for in situ cellular analysis and purification. LEAP combines high-speed whole well imaging and ultra fast...
|
Dalton Pharma Services Dalton Pharma Services (Dalton Chemical Laboratories) has become a leading pharmaceutical contract manufacturing company. We provide a number of invaluable services to pharmaceutical and research communities across...
|
DAVOSPHARMA DavosPharma is the leading provider of chemistry and pharmaceutical services, offering solutions to many of the problems faced by both emerging biotechs and established multinationals during drug development.
It...
|
deCODE chemistry deCODE chemistry & biostructures takes a collaborative approach to pharmaceutical research services by combining the expertise of deCODE chemistry in drug discovery and chemical development with the expertise of deCODE...
|
DelSite Biotechnologies DelSite Biotechnologies is an early stage drug-delivery and biotechnology company established to provide the pharmaceutical and biotechnology industries with novel delivery solutions for new and existing proteins and...
|
Dow Pharmaceutical Sciences Topical formulation development has been Dow’s focus for more than 33 years. Dow helps clients with early feasibility studies through proof of concept in man and on to NDA.
Topical Formulations Development
Multiple formulation prototypes are evaluated for API release and penetration in our in vitro drug transport laboratory, and are then optimized for maximum...
|
DPT LABORATORIES, LTD DPT is the contract development and manufacturing organization (CDMO) that specializes in semi-solid and liquid dosage forms. With unmatched technical expertise and fully integrated drug development and manufacturing...
Formulation Services
Particle size (dry, wet, and sprays).Informal stability/Formulation stress testing (both physical and chemical)
Pre-formulation Services
Raw material sourcing.Method development and method transfer for particle size of wet and dry particles by laser diffraction (for both API and the...
|
DSM Pharmaceutical Products DSM Pharmaceutical Products is the custom manufacturing and technology resource within Royal DSM NV – a global life sciences and materials sciences company that delivers innovative products and services to create...
Pharmaceutical Development Services
With numerous annual product launches and almost four decades of experience on site, our services bring added value to customers in terms of cost reduction...
|
EMD Millipore Bioscience EMD Millipore Bioscience delivers new technologies & workflow solutions that enable researchers to understand complex biological systems & identify new targets.
|
Emerson Resources Inc Emerson Resources’ reputation as a dependable, dynamic, flexible, and pragmatic organization has been built on the core concepts of excellent service, superb quality and complete client satisfaction. The Emerson mission...
Formulation Development
cGMP PHASE I AND PHASE II CLINICAL TRIAL MATERIAL:
Flawless clinical supply manufacturing means getting to market faster
|
EmulTech EmulTech is a formulation development and technology company dedicated to the innovative formulation of drug delivery systems for (bio)molecules, that expand the delivery, bioavailabilty, and efficacy of...
|
|
53 - 65 of 146
|
|
|
|
More
Formulation Management
Research Library
|
|
AAIPharma Services Corp.
|
Collaboration Leads to World-Wide Disinfectant Qualification and Lifting of FDA Consent Decree
Challenge Having not qualified its disinfectants to FDA standards, a pharmaceutical company was under a consent decree to do so within the year. To achieve this goal, the company contracted with AAIPharma Services to acquire the testing materials, develop and execute the protocols and cover each of its ...
|
|
|
Capsugel
|
The BCS attempts to identify when dissolution rate is likely to be rate-determining, and to assess when in-vitro/in-vivo correlations would be ex- pected. And that would be, of course, the Class I type of drug, where dissolution is rapid and not the rate-determining step, plasma levels may not reflect product differences, and little or no difference would be expected between oral solutions and ...
|
|
|
Metrics, Inc
|
Dissolution of a Phosphate Prodrug from Hard Gelatin Capsules: A Case Study Thomas B. Gold, Jennifer G. Warren, and David R. Collier
OBJECTIVE To compare dissolution of a phosphate prodrug from three capsule shell types.
BACKGROUND Clinical studies often include an active comparator (an active control) in the specific study design. The respective design compares the standard therapy ...
|
|
|
Ropack
|
Paul Dupont explains how growing trends in the consumer healthcare industry signal promising market opportunities for leading nutraceutical and pharmaceutical companies.
W hile originally regarded strictly as a specialty market, probiotic supplements are now main- stream. According to LexisNexis, 231 probiotic products were launched in 2008, compared with 34 just three years prior; 75 percent of ...
|
|
|
CoreRx Pharmaceuticals
|
Very few businesses have as specialized a set of needs as those in the pharmaceutical sector. The
combination of huge product development costs, large amounts of data and intense regulatory control
makes it critical for companies to have needed information as soon as possible in order to meet a
varied and closely monitored set of business processes.
Time is money – a fact well understood by those ...
|
|
|
|
|
|
|
Formulation Management
Video
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
